Abiomed Inc (ABMD.O) Company Profile | Reuters.com
United States

Profile: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

1 Jul 2016
Change (% chg)

$0.88 (+0.81%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Abiomed, Inc., incorporated on June 4, 1987, is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's products include Impella 2.5, Impella CP, Impella 5.0 and Impella LD, Impella RP, AB5000 and Symphony.

Impella 2.5

The Impella 2.5 catheter is a percutaneous micro heart pump with an integrated motor and sensors. The device is designed primarily for use by interventional cardiologists to support patients in the catheter lab who may require assistance to maintain their circulation. The Impella 2.5 catheter can be inserted through the femoral artery to reach the left ventricle of the heart where it is deployed to draw blood out of the ventricle and deliver it to the circulatory system. The Impella 2.5 is introduced with normal interventional cardiology procedures and can pump around 2.5 liters of blood per minute.

Impella CP

The Impella CP is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite. The Impella CP provides blood flow of approximately one liter more per minute than the Impella 2.5. The Impella CP is indicated for up to six hours of partial circulatory support using an extracorporeal bypass control unit.

Impella 5.0 and Impella LD

The Impella 5.0 and Impella LD are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. These devices are designed to support patients who require higher levels of circulatory support. The Impella 5.0 can be inserted into the left ventricle through femoral cut down or through the axillary artery. The Impella 5.0 pump goes through the ascending aorta, across the valve and into the left ventricle. The Impella 5.0 and Impella LD can pump up to five liters of blood per minute, providing circulatory support.

Impella RP

The Impella RP is a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute. The Impella RP is a percutaneous device approved to provide support of the right heart during times of acute failure for certain patients who have received a left ventricle assist device or have suffered heart failure due to acute myocardial infarction (AMI) or a failed heart transplant.


The Company manufactures and sells the AB5000 Circulatory Support System for the temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. AB5000 is a cardiac assist device that is approved by the U.S. Food and Drug Administration for all indications where heart recovery is the desired outcome, including patients who have undergone cardiac surgery and develop low cardiac output, or patients who suffer from acute cardiac disorders leading to hemodynamic instability.


Symphony is a minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics. The device is designed for stabilizing the progression of heart failure and recovering or remodeling the heart.

The Company competes with Getinge, Teleflex Inc., Thoratec Corporation, HeartWare International Inc., Terumo Heart, Inc. and CardiacAssist Inc.

Company Address

Abiomed Inc

DANVERS   MA   01923-2575
P: +1978.7775410
F: +1978.7778411

Company Web Links